BIRC3 and non-small cell lung carcinoma: Taken together, cIAP1 expression is an independent factor that can be used to evaluate prognosis in NSCLC patients, with cIAP1 expression predicting a poorer prognosis, especially in patients whose tumors are positive for cIAP2.